Pabitra H. Patra

Transpharmation Ltd. Discovery Park
Sandwich, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Trafficking and potentiation of Nav1.7 and Nav1.8 channels are mediated by IQGAP1.

Trafficking and potentiation of Nav1.7 and Nav1.8 channels are mediated by IQGAP1.

Journal: The Journal of physiology

Published: November 11, 2025

The NLRP3 inflammasome: A central player in multiple sclerosis.

The NLRP3 inflammasome: A central player in multiple sclerosis.

Journal: Biochemical pharmacology

Published: September 13, 2024

IQGAP1 promotes chronic pain by regulating the trafficking and sensitization of TRPA1 channels.

IQGAP1 promotes chronic pain by regulating the trafficking and sensitization of TRPA1 channels.

Journal: Brain : a journal of neurology

Published: August 26, 2022

Pro-opiomelanocortin neurons in the nucleus of the solitary tract mediate endorphinergic endogenous analgesia in mice.

Pro-opiomelanocortin neurons in the nucleus of the solitary tract mediate endorphinergic endogenous analgesia in mice.

Journal: Pain

Published: October 30, 2021

1,8-Cineole Affects Agonists-Induced Platelet Activation, Thrombus Formation and Haemostasis.

1,8-Cineole Affects Agonists-Induced Platelet Activation, Thrombus Formation and Haemostasis.

Journal: Cells

Published: July 20, 2021

Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.

Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.

Journal: Neuron

Published: August 12, 2020

Evaluation of ameliorative effect of two selected plant drugs on experimentally induced arsenic toxicity in sheep.

Evaluation of ameliorative effect of two selected plant drugs on experimentally induced arsenic toxicity in sheep.

Journal: Environmental science and pollution research international

Published: December 20, 2019

Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice.

Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice.

Journal: British journal of pharmacology

Published: August 21, 2019

Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.

Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.

Journal: European journal of pharmacology

Published: April 27, 2019

A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models.

A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models.

Journal: British journal of pharmacology

Published: April 24, 2019

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.

Journal: Epilepsia

Published: October 15, 2018

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Journal: Epilepsy & behavior : E&B

Published: October 01, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026